SEC Form 4 · accession 0001562180-18-003331

Intersect ENT, Inc. · XENT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — President and CEO · Director

Period of report

Jul 16, 2018

Accepted (ET)

Jul 18, 2018 · 6:09 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001271214

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Jul 16, 2018	M	5,000	$13.05	A	474,683	D
Common Stock^F2	Jul 16, 2018	S	20,000	$33.0843	D	454,683	D
Common Stock^F3	holding	—	—		—	26,182	I	See footnote

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (right to buy)^F4	$13.05	Jul 16, 2018	M	5,000	D	—	Jan 17, 2027	Common Stock	5,000	182,000	D

F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2017.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.90 to $33.55, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
F3Shares in the name of Lisa Damkroger Earnhardt C/F Jack L. Earnhardt UTMA/CA Until Age 25 for the benefit of Reporting Person's son. Reporting Person disclaims beneficial ownership of these shares.
F4The vesting commencement date of the option is January 1, 2017. 1/8th of the shares subject to the option shall vest on July 1, 2017 and 1/48th of the shares subject to the option shall vest monthly thereafter over 42 months.